Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Cardiotoxicity of Commonly Used Drugs in Hsct Publisher



Shahrami B1, 2 ; Vaezi M2
Authors

Source: Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation Published:2024


Abstract

Many drugs used in hematopoietic stem cell transplantation (HSCT) Hematopoietic Stem Cell Transplantation (HSCT) settings have the potential to cause adverse cardiovascular effects. Drug-induced cardiotoxicity Cardiotoxicity is a serious adverse effect with a high rate of morbidity and mortality in patients undergoing autologous or Allogeneic HSCT allogeneic HSCT. The mechanism of drug-induced cardiotoxicity can involve direct or indirect damage to cardiac cells. Furthermore, these toxicities may manifest either early or late. There are several risk factors that can increase an individual's susceptibility to cardiotoxicity. Identifying prevention and management strategies for cardiac complications Cardiac complications induced by drugs is crucial. © Springer Nature Switzerland AG 2024. All rights reserved.
1. Risk Factors and Mechanisms of Cardiotoxicity in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
3. Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
Experts (# of related papers)
Other Related Docs
4. Post-Transplant Cyclophosphamide-Induced Cardiotoxicity: A Comprehensive Review, Journal of Cardiovascular and Thoracic Research (2024)
5. Rehabilitation in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
6. Long Term Cardiotoxicity Surveillance in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
9. Pericardial Disease in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
12. Pre-Hsct Cardiovascular Evaluation, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
13. Evaluation of the Effect of Crocin on Doxorubicin-Induced Cardiotoxicity, Advances in Experimental Medicine and Biology (2021)
16. Cardiovascular Pharmacology in Pediatric Patients With Congenital Heart Disease, Congenital Heart Disease in Pediatric and Adult Patients: Anesthetic and Perioperative Management (2017)